bibliographic entry 6777943 [be/6777943]
https://w3id.org/oc/corpus/be/6777943

is a
content
  • Tang, X, Li, Q, Zhu, Y, Zheng, D, Dai, J, Ni, W, Wei, J, Xue, Y, Chen, K, Hou, W, Zhang, C, Feng, X, Liang, Y. The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy, American journal of translational research, 2015, 7, 460, 473, PMID: 26045887
references